OTC · Financial Statements
LianBio (LIANY) Financial Statements
$0.07
OTC: LIANY
Market Cap $7.64M
Overview Financials Dividend
LianBio most recently reported annual revenue of $0, net profit of $5.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $0 $0 $0 $0 $0 Operating Profit $-196.0M $-125.0M $-100.0M $-39.0M $-1.0M Net Profit $-197.0M $-110.0M $311.0M $2.0M $5.0M EPS $-1.83 $-1.02 $2.87 $0.02 $0.05 Op Margin — — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $426.0M $320.0M $618.0M $64.0M $21.0M Total Liabilities $39.0M $26.0M $37.0M $1.0M $0 Cash $228.0M $79.0M $439.0M $52.0M $9.0M Borrowings $5.0M $4.0M $2.0M $0 $0
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $-164.0M $-99.0M $259.0M $4.0M $5.0M Investing Cash Flow $-157.0M $-71.0M $99.0M $129.0M $0 Financing Cash Flow $0 $0 $0 $0 $0 Net Cash Flow $-26.0M $-149.0M $359.0M $-387.0M $-42.0M Free Cash Flow $-165.0M $-101.0M $259.0M $4.0M $5.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA 1.38 FCF Yield 64.81% Quick Ratio 1466.01 Interest Coverage — Return 1Y 40.00% Return 3Y -5081.75% Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .